7. Will the First Minister respond to the call from Ovarian Cancer Action for a national clinical audit of ovarian cancer in Wales? OAQ52133

Tthe clinical audit and outcome review programme for the NHS doesn't include provision—that's true—for a national clinical audit of ovarian cancer services. We do, however, encourage ovarian cancer charities in Wales to approach the Wales Cancer Network to consider alternative approaches for reviewing services.

Thank you, First Minister. You'll be aware that today, in fact, is World Ovarian Cancer Day. On Mother's Day, I joined hundreds of others on a walk in memory of Lesley Woolcock from Barry, who was a tireless campaigner on ovarian cancer who sadly passed away in 2016.

According to Ovarian Cancer Action, ovarian cancer is the UK's deadliest gynaecological cancer, and the UK has one of the lowest survival rates in western Europe. So, an ovarian cancer audit could provide the data to help find out why this is and where the challenges lie. And, of course, recognising the importance of national clinical audits—and they have improved survival rates for lung, bowel and head and neck cancers—I understand that Scotland has just completed an ovarian cancer audit, and the chief medical officer in England has called for an audit. So, I hope, indeed, there will be consideration for an audit for women in Wales.

Well, there already exist clinical audits for a number of other cancers, as the Member clearly pointed out. We keep an open mind on whether clinical audits are appropriate for all cancers, but what I can say is that there is already a system in place in order to examine the way in which ovarian cancer is detected and, indeed, treated—that's part of the approach set out in the cancer delivery plan for Wales. We do have a significant amount of data on ovarian cancer that is provided by the Wales cancer registry, and we do learn from that in terms of what impacts cancer survival through our participation, for example, in international studies. 

I can also assure Members that ovarian cancer services are subject to a peer review programme. That has taken place this year, and that is intended, of course, to support quality improvements in services.

And finally, question 8, Llyr Gruffydd.